Akari Therapeutics Plc (AKTX) shareholders
Close on Nov 17, 2026Market cap $11.10MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Hoyoung Huh, M.D., Ph.D. | 18,199,697,667 | 18.40% | 13G (passive) amendment | Mar 2, 2026 |
| Samir R. Patel | 9,725,215,000 | 10.40% | 13D (active) amendment | Mar 2, 2026 |
| Ray Prudo, M.D. | 8,391,326,467 | 8.90% | 13D (active) amendment | Mar 2, 2026 |
| Bmo Nesbitt Burns Inc. Joint filing with Bank of Montreal (5.71%), Bank Of Montreal Holding Inc. (5.71%) | 8,000,000,000 | 5.71% | 13G (passive) | Jun 30, 2026 |
| MMCAP International Inc. SPC Joint filing with MM Asset Management Inc. (8.00%) | 8,000,000,000 | 8.00% | 13G (passive) | Jun 2, 2026 |
| White Lion Capital LLC | 7,001,638,477 | 5.00% | 13G (passive) | Aug 7, 2026 |
| Ray Prudo, M.D | 4,507,314,800 | 19.20% | 13D (active) amendment | May 31, 2024 |
| Kathryn Theofilos Joint filing with Charles Steve Theofilos, M.D (9.99%) | 2,370,750,000 | 9.99% | 13D (active) | May 31, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of AKTX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| MMCAP International Inc. SPC | 100,000 | 0.00% | $1.02M | New | 0.09% |
| Cresset Asset Management, LLC | 20,561 | 0.00% | $210.65K | – | 0.00% |
| Jane Street Group, LLC | 15,463 | 0.00% | $158.42K | New | 0.00% |
| Hrt Financial LP | 13,745 | 0.00% | $140.00K | New | 0.00% |
| IFP Advisors, Inc | 181 | 0.00% | $1.85K | −7,250 | 0.00% |
| SBI Securities Co., Ltd. | 14 | 0.00% | $143 | +9 | 0.00% |
| Caitong International Asset Management Co., Ltd | 8 | 0.00% | $82 | New | 0.00% |
| Northwestern Mutual Wealth Management Co | 7 | 0.00% | $72 | New | 0.00% |
| Truvestments Capital LLC | 1 | 0.00% | $10 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 9 | 0M | 0.0% | 5 / 1 | 1 / 2 | 0M | 0M |
| Q1 2026 | 6 | 0M | 0.0% | 1 / 1 | 2 / 15 | 0M | 0M |
| Q4 2025 | 21 | 0M | 0.0% | 9 / 3 | 1 / 4 | 0M | 0M |
| Q3 2025 | 16 | 0M | 0.0% | 3 / 1 | 3 / 2 | 0M | 0M |
| Q2 2025 | 15 | 0M | 0.0% | 5 / 0 | 2 / 1 | 0M | 0M |
| Q1 2025 | 11 | 0M | 0.0% | 1 / 0 | 1 / 4 | 0M | 0M |
| Q4 2024 | 14 | 0M | 0.0% | 5 / 1 | 0 / 1 | 0M | 0M |
| Q3 2024 | 10 | 0M | 0.0% | 2 / 1 | 0 / 2 | 0M | 0M |
| Q2 2024 | 10 | 0M | 0.0% | 4 / 1 | 0 / 2 | 0M | 0M |
| Q1 2024 | 8 | 0M | 0.0% | 2 / 1 | 0 / 1 | 0M | 0M |
| Q4 2023 | 7 | 0M | 0.0% | 2 / 1 | 1 / 2 | 0M | 0M |
| Q3 2023 | 7 | 0M | 0.0% | 7 / 0 | 0 / 0 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Abizer Gaslightwala | CEO, Director | 41,173 | 0.00% | Oct 16, 2026 |
| Vatnak Vat-Ho | Chief Business Officer | – | – | Oct 14, 2026 |
| Kameel D. Farag | Interim CFO | 23,309 | 0.00% | Aug 19, 2026 |
| Torsten Hombeck | CFO | 200 | 0.00% | Mar 24, 2025 |
| Robert B. Bazemore | Director | 22,759 | 0.00% | Oct 16, 2026 |
| Raymond Prudo-Chlebosz | Director | 496,599 | 0.00% | Oct 16, 2026 |
| Samir Rashmikant Patel | Director | 110,343 | 0.00% | Oct 16, 2026 |
| Hoyoung Huh | Director, 10% owner | 250,262 | 0.00% | Oct 16, 2026 |
| Sandip I. Patel | Director | 99,127 | 0.00% | Oct 16, 2026 |
| James R. Neal | Director | 36,271 | 0.00% | Mar 16, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Sandip I. Patel Director | Oct 14, 2026 | Option exercise | +6,186 | $0.00 | $2 | 38,877 |
| Sandip I. Patel Director | Oct 14, 2026 | Option exercise | +3,866 | $0.00 | $2 | 32,691 |
| Robert B. Bazemore Director | Oct 14, 2026 | Option exercise | +3,093 | $0.00 | $1 | 22,759 |
| Robert B. Bazemore Director | Oct 14, 2026 | Option exercise | +773 | $0.00 | $0 | 19,666 |
| Abizer Gaslightwala CEO, Director | Oct 14, 2026 | Option exercise | +7,733 | $0.00 | $3 | 41,173 |
| Abizer Gaslightwala CEO, Director | Oct 14, 2026 | Option exercise | +19,333 | $0.00 | $8 | 33,440 |
| Raymond Prudo-Chlebosz Director | Oct 5, 2026 | Award | +3,240 | $7.90 | $25.59K | 76,861 |
| Hoyoung Huh Director, 10% owner | Oct 5, 2026 | Award | +6,160 | $7.90 | $48.66K | 140,805 |
| Sandip I. Patel Director | Oct 5, 2026 | Award | +4,313 | $7.90 | $34.07K | 28,825 |
| Robert B. Bazemore Director | Oct 5, 2026 | Award | +4,677 | $7.90 | $36.94K | 18,893 |
| Samir Rashmikant Patel Director | Oct 5, 2026 | Award | +2,236 | $7.90 | $17.66K | 12,102 |
| Abizer Gaslightwala CEO, Director | Sep 29, 2026 | Award | +6,430 | $9.72 | $62.50K | 14,107 |
| Raymond Prudo-Chlebosz Director | Aug 18, 2026 | Award | +9,072 | $7.90 | $71.66K | 73,621 |
| Hoyoung Huh Director, 10% owner | Aug 18, 2026 | Award | +17,249 | $7.90 | $136.25K | 134,645 |
| Sandip I. Patel Director | Aug 18, 2026 | Award | +12,100 | $7.90 | $95.58K | 24,512 |
| Robert B. Bazemore Director | Aug 18, 2026 | Award | +13,100 | $7.90 | $103.48K | 14,216 |
| Samir Rashmikant Patel Director | Aug 18, 2026 | Award | +6,300 | $7.90 | $49.76K | 9,866 |
| Kameel D. Farag Interim CFO | Aug 17, 2026 | Award | +1,728 | $7.52 | $12.99K | 23,309 |
| Kameel D. Farag Interim CFO | Jul 16, 2026 | Award | +1,130 | $11.50 | $13.00K | 21,581 |
| Samir Rashmikant Patel Director, 10% owner | Jul 7, 2026 | Option exercise | +5,799 | – | – | 98,241 |
| Samir Rashmikant Patel Director, 10% owner | Jul 7, 2026 | Option exercise | +15,466 | – | – | 92,442 |
| Samir Rashmikant Patel Director, 10% owner | Jul 7, 2026 | Option exercise | +1,209 | $8.00 | $9.67K | 76,976 |
| Kameel D. Farag Interim CFO | Jun 24, 2026 | Award | +1,248 | $10.02 | $12.50K | 2,870 |
| Kameel D. Farag Interim CFO | Jun 24, 2026 | Award | +1,395 | $9.32 | $13.00K | 4,265 |
| Kameel D. Farag Interim CFO | Jun 24, 2026 | Award | +3,725 | $3.49 | $13.00K | 12,099 |
| Kameel D. Farag Interim CFO | Jun 24, 2026 | Award | +2,539 | $5.12 | $13.00K | 8,374 |
| Kameel D. Farag Interim CFO | Jun 24, 2026 | Award | +1,000 | $13.00 | $13.00K | 20,452 |
| Kameel D. Farag Interim CFO | Jun 24, 2026 | Award | +7,353 | $3.74 | $27.50K | 19,452 |
| Kameel D. Farag Interim CFO | Jun 24, 2026 | Award | +1,570 | $8.28 | $13.00K | 5,835 |
| Kameel D. Farag Interim CFO | Nov 1, 2025 | Award | +32,000 | $0.75 | $24.00K | 32,000 |
| Kameel D. Farag Interim CFO | Nov 1, 2025 | Award | +26,619 | $0.75 | $19.96K | 26,619 |
| Kameel D. Farag Interim CFO | Oct 22, 2025 | Award | +6,277 | $0.74 | $4.64K | 6,277 |
| Abizer Gaslightwala CEO, Director | Aug 25, 2025 | Buy | +3,000 | $0.90 | $2.70K | 298,574 |
| Abizer Gaslightwala CEO, Director | Aug 22, 2025 | Buy | +8,000 | $0.93 | $7.44K | 295,574 |
| Abizer Gaslightwala CEO, Director | Aug 21, 2025 | Buy | +10,000 | $0.94 | $9.40K | 287,574 |
| Abizer Gaslightwala President & CEO, Director | Jun 24, 2025 | Buy | +5,203 | $1.16 | $6.04K | 277,574 |
| Abizer Gaslightwala President & CEO, Director | Jun 23, 2025 | Buy | +943 | $1.15 | $1.08K | 272,371 |
| Abizer Gaslightwala President & CEO, Director | Jun 20, 2025 | Buy | +10,000 | $1.20 | $12.00K | 271,428 |
| Abizer Gaslightwala President & CEO, Director | Jun 17, 2025 | Buy | +15,000 | $1.20 | $18.00K | 261,428 |
| Abizer Gaslightwala CEO, Director | Jun 13, 2025 | Award | +25,000 | $1.19 | $29.75K | 246,428 |
| Abizer Gaslightwala CEO, Director | Jun 12, 2025 | Award | +20,000 | $1.23 | $24.60K | 221,428 |
| Abizer Gaslightwala CEO, Director | Jun 10, 2025 | Award | +20,000 | $1.27 | $25.40K | 201,428 |
| Sandip I. Patel Director | Mar 6, 2025 | Award | +44,642 | $1.12 | $50.00K | 496,499 |
| Hoyoung Huh Director, 10% owner | Mar 6, 2025 | Award | +892,857 | $1.12 | $1,000.00K | 4,695,854 |
| Samir Rashmikant Patel Director | Mar 6, 2025 | Award | +406,250 | $1.12 | $455.00K | 3,031,005 |
| James R. Neal Director | Mar 6, 2025 | Award | +4,464 | $1.12 | $5.00K | 36,271 |
| Abizer Gaslightwala Director | Mar 6, 2025 | Award | +133,928 | $1.12 | $150.00K | 181,428 |
| Raymond Prudo-Chlebosz Director | Mar 6, 2025 | Award | +446,428 | $1.12 | $500.00K | 2,484,990 |
| Robert B. Bazemore Director | Mar 6, 2025 | Award | +44,642 | $1.12 | $50.00K | 44,642 |
| Abizer Gaslightwala Director | Jan 10, 2025 | Award | +11,640 | $1.22 | $14.20K | 47,500 |
| Abizer Gaslightwala Director | Jan 10, 2025 | Award | +11,439 | $1.22 | $13.96K | 35,860 |
| Torsten Hombeck CFO | Jan 10, 2025 | Award | +200 | $1.22 | $244 | 200 |
| James R. Neal Director | Jan 9, 2025 | Award | +8,000,000 | – | – | 32,216,000 |
| Samir Rashmikant Patel Director | Jan 3, 2025 | Award | +208,000 | – | – | 5,249,511,500 |
| Abizer Gaslightwala Director | Jan 3, 2025 | Award | +1,720,000 | – | – | 71,720,000 |
| Abizer Gaslightwala Director | Dec 27, 2024 | Award | +40,000,000 | – | – | 70,000,000 |
| Samir Rashmikant Patel Director | Dec 27, 2024 | Award | +400,000 | – | – | 5,249,303,500 |
| Samir Rashmikant Patel Director | Dec 26, 2024 | Award | +3,200,000 | – | – | 5,248,903,500 |
| Abizer Gaslightwala Director | Dec 26, 2024 | Award | +30,000,000 | – | – | 30,000,000 |
| Samir Rashmikant Patel Director | Dec 24, 2024 | Award | +7,500,000 | – | – | 5,245,703,500 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Akari Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 5,517 shares on Aug 28, 2026 over the last 90 days.
See a number that looks wrong?